Antineoplaston Therapy in Treating Patients With Brain Tumors

Completed · Phase 2

Conditions studied: Refractory Brain Tumors

In brief

RATIONALE: Current therapies for adults with persistent or recurrent brain tumors provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of adults with persistent or recurrent brain tumors. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on adults with persistent or recurrent brain tumors.

Key facts

Study ID

NCT00003457

Run by

Burzynski Research Institute

People needed

40

Starts

1996-07-01

Expected to finish

2012-02-01

Last updated by the study team

2017-08-22

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Burzynski Clinic — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.